User contributions
Jump to navigation
Jump to search
- 02:16, 16 December 2021 diff hist -16 m Classical Hodgkin lymphoma - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:15, 16 December 2021 diff hist -2 m B-cell acute lymphoblastic leukemia Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:15, 16 December 2021 diff hist -16 m Thrombocytopenia in liver disease Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:15, 16 December 2021 diff hist -10 m CNS leukemia Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:15, 16 December 2021 diff hist -2 m Kaposi sarcoma - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:15, 16 December 2021 diff hist -6 m Anaplastic glioma - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:15, 16 December 2021 diff hist -1,054 m Breast cancer Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:14, 16 December 2021 diff hist -4 m Light-chain (AL) amyloidosis - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:14, 16 December 2021 diff hist -28 m CNS carcinoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:14, 16 December 2021 diff hist -12 m Multiple myeloma - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:14, 16 December 2021 diff hist -10 m T-cell acute lymphoblastic leukemia, pediatric Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:12, 16 December 2021 diff hist -2 m Neuroendocrine tumor - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:12, 16 December 2021 diff hist -158 m Non-small cell lung cancer, nonsquamous Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:12, 16 December 2021 diff hist -8 m Warm autoimmune hemolytic anemia Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:11, 16 December 2021 diff hist -4 m B-cell acute lymphoblastic leukemia, pediatric, Ph-positive Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:10, 16 December 2021 diff hist -36 m Acute myeloid leukemia - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:10, 16 December 2021 diff hist -2 m Stem cell mobilization regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:10, 16 December 2021 diff hist -6 m B-cell acute lymphoblastic leukemia, Ph-positive Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:10, 16 December 2021 diff hist -2 m Osteosarcoma - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:10, 16 December 2021 diff hist -162 m Follicular lymphoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:10, 16 December 2021 diff hist -252 m Acute myeloid leukemia Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:10, 16 December 2021 diff hist -16 m Prostate cancer - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:10, 16 December 2021 diff hist -6 m Acute promyelocytic leukemia - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:09, 16 December 2021 diff hist -4 m B-cell acute lymphoblastic leukemia - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:08, 16 December 2021 diff hist -14 m Classical Hodgkin lymphoma - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:08, 16 December 2021 diff hist -10 m Pancreatic NET - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:06, 16 December 2021 diff hist -8 m Editing test page 2 Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:06, 16 December 2021 diff hist -20 m Smoldering multiple myeloma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:06, 16 December 2021 diff hist -20 m Thyroid cancer, differentiated Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:06, 16 December 2021 diff hist -2 m Subependymal giant cell astrocytoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:06, 16 December 2021 diff hist -2 m Papillary renal cell carcinoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:06, 16 December 2021 diff hist -44 m Renal cell carcinoma - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:06, 16 December 2021 diff hist -12 m Liposarcoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:06, 16 December 2021 diff hist -4 m Colorectal cancer, BRAF-mutated Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:05, 16 December 2021 diff hist -20 m Gastric cancer - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:04, 16 December 2021 diff hist -108 m Breast cancer, triple negative Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:04, 16 December 2021 diff hist -4 m Chronic myeloid leukemia Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:03, 16 December 2021 diff hist -4 m Low-grade glioma, pediatric Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:03, 16 December 2021 diff hist -50 m Immune thrombocytopenia Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:01, 16 December 2021 diff hist -8 m Hepatoblastoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:01, 16 December 2021 diff hist -2 m Mantle cell lymphoma - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:01, 16 December 2021 diff hist -22 m Rhabdomyosarcoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:00, 16 December 2021 diff hist -54 m Esophageal adenocarcinoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:00, 16 December 2021 diff hist -130 m Renal cell carcinoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 02:00, 16 December 2021 diff hist -10 m Cervical cancer - null regimens Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:59, 16 December 2021 diff hist -6 m Nasopharyngeal carcinoma Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:57, 16 December 2021 diff hist -20 m Gastric cancer, HER2-positive Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:57, 16 December 2021 diff hist -12 m Paroxysmal nocturnal hemoglobinuria Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:57, 16 December 2021 diff hist -2 m Soft tissue sarcoma - historical Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"
- 01:57, 16 December 2021 diff hist -4 m Non-Hodgkin lymphoma, pediatric Text replacement - "style="background-color:#1a9851" |Phase III" to "style="background-color:#1a9851" |Phase 3"